LIPONEX INC. ANNOUNCES RESULTS FOR YEAR ENDED DECEMBER 31, 2005
Liponex Inc., a biopharmaceutical company specializing in developing advanced
products related to High Density Lipoprotein (HDL), often called "good cholesterol,"
today announced its results for the year ended December 31, 2005. "In 2005
we were able to take the first step toward moving our lead compound into later
stage clinical testing by successfully completing our initial public offering,"
said Bill Dickie, President and CEO.